Drug intelligence / Profile preview

9-hydroxy-6-(3-hydroxypropyl)-4-(2-methoxyphenyl)pyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione

Development stage: Unknown
Modality: Small Molecules

Overview

A synthetic small molecule with the chemical formula C24H20N2O5 and a molecular weight of approximately 416.43 g/mol. It is structurally classified as a pyrrolocarbazole derivative. There are no approved medical indications or clinical trials reported for this compound. Its mechanism of action and pharmacological properties have not been described in publicly available sources as of June 2025.

Other names: 9-hydroxy-6-(3-hydroxypropyl)-4-(2-methoxyphenyl)pyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione9-hydroxy-6-(3-hydroxypropyl)-4-(2-methoxyphenyl)-1h,2h,3h,6h-pyrrolo[3,4-c]carbazole-1,3-dione

Beyond the preview

Go deeper on 9-hydroxy-6-(3-hydroxypropyl)-4-(2-methoxyphenyl)pyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 9-hydroxy-6-(3-hydroxypropyl)-4-(2-methoxyphenyl)pyrrolo[3,4-c]carbazole-1,3(2H,6H)-dione.

Explore the full profile